Diabetic Neuropathies
4 competing products in clinical development for Diabetic Neuropathies.
Pipeline by Phase
Phase 21
Phase 33
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Ruboxistaurin mesylate | Eli Lilly | Phase 3 | Completed | 40 |
| Duloxetine hydrochloride + Duloxetine hydrochloride | Shionogi | Phase 3 | Completed | 40 |
| Duloxetine hydrochloride - 40 mg + placebo + Duloxetine hydrochloride - 60 mg | Shionogi | Phase 3 | Completed | 40 |
| ASP8825 + Placebo | Astellas Pharma | Phase 2 | Terminated | 27 |